plerixafor has been researched along with Neoplasms, Pleural in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, S; Kadoch, O; Li, H; Li, J; Li, S; Li, T; Lin, Q; Xie, L; Xu, Z; Yang, YL | 1 |
| Au, A; Harvard, C; Jablons, DM; Li, H; Li, T; Tan, JL; Wang, Y; Xu, Z; You, L | 1 |
2 other study(ies) available for plerixafor and Neoplasms, Pleural
| Article | Year |
|---|---|
Experimental study of the inhibition effect of CXCL12/CXCR4 in malignant pleural mesothelioma.
Topics: Animals; Benzylamines; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Luminescent Measurements; Lung Neoplasms; Mesothelioma; Mesothelioma, Malignant; Mice, Inbred BALB C; Mice, Nude; Pemetrexed; Pleural Neoplasms; Protein Isoforms; Receptors, CXCR4; Signal Transduction | 2019 |
The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma.
Topics: Benzylamines; Biomarkers, Tumor; Cell Proliferation; Cell Survival; Chemokine CXCL12; Cyclams; Heterocyclic Compounds; Humans; Mesothelioma; Neoplasm Proteins; Oncogene Protein v-akt; Pleural Neoplasms; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Cells, Cultured | 2011 |